Effect of Vilanterol on Methacholine Challenge Results
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The study will assess the degree of bronchoprotection provided by the ultra long-acting beta2
agonist vilanterol against methacholine-induced bronchoconstriction.